291 related articles for article (PubMed ID: 11229611)
21. Peritoneal transport after long-term exposure to Icodextrin in rats.
Frajewicki V; Kushnir D; Wajsbrot V; Kohan R; Shostak A; Gotloib L
Nephron; 2002 Sep; 92(1):174-82. PubMed ID: 12187100
[TBL] [Abstract][Full Text] [Related]
22. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
23. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
25. Icodextrin and intraperitoneal inflammation.
Moriishi M; Kawanishi H
Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
[TBL] [Abstract][Full Text] [Related]
26. Chronic peritoneal dialysis in iron-deficient rats with solutions containing iron dextran.
Reddy DK; Moore HL; Lee JH; Saran R; Nolph KD; Khanna R; Twardowski ZJ
Kidney Int; 2001 Feb; 59(2):764-73. PubMed ID: 11168960
[TBL] [Abstract][Full Text] [Related]
27. Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: one center's experience and review of the literature.
Dousdampanis P; Trigka K; Chu M; Khan S; Venturoli D; Oreopoulos DG; Bargman JM
Int Urol Nephrol; 2011 Mar; 43(1):203-9. PubMed ID: 20953705
[TBL] [Abstract][Full Text] [Related]
28. Peritoneal accumulation of AGE and peritoneal membrane permeability.
Park MS; Lee HA; Chu WS; Yang DH; Hwang SD
Perit Dial Int; 2000; 20(4):452-60. PubMed ID: 11007378
[TBL] [Abstract][Full Text] [Related]
29. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
[TBL] [Abstract][Full Text] [Related]
30. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
Opatrna S; Popperlova A; Kalousová M; Zima T
Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
[TBL] [Abstract][Full Text] [Related]
31. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
[TBL] [Abstract][Full Text] [Related]
32. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
[TBL] [Abstract][Full Text] [Related]
33. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
34. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.
Ha H; Cha MK; Choi HN; Lee HB
Perit Dial Int; 2002; 22(2):171-7. PubMed ID: 11990400
[TBL] [Abstract][Full Text] [Related]
35. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis.
Woodrow G; Stables G; Oldroyd B; Gibson J; Turney JH; Brownjohn AM
Nephrol Dial Transplant; 1999 Jun; 14(6):1530-5. PubMed ID: 10383020
[TBL] [Abstract][Full Text] [Related]
36. Effect of icodextrin on heart rate variability in diabetic patients on peritoneal dialysis.
Orihuela O; de Jesús Ventura M; Ávila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Alcántara G; Lindholm B; García-López E; Villanueva C; Paniagua R
Perit Dial Int; 2014; 34(1):57-63. PubMed ID: 24525598
[TBL] [Abstract][Full Text] [Related]
37. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
38. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
[TBL] [Abstract][Full Text] [Related]
39. Osmotic agents hamper mesothelial repopulation as seen in the doughnut in vivo model.
Gotloib L; Wajsbrot V; Shostak A
Perit Dial Int; 2005 Feb; 25 Suppl 3():S26-30. PubMed ID: 16048251
[TBL] [Abstract][Full Text] [Related]
40. Influence of osmotic and oncotic factors on gentamicin and insulin transport across the peritoneal membrane in vitro.
Grzelak T; Wojciechowska K; Szary B; Czyzewska K
Adv Perit Dial; 2011; 27():16-21. PubMed ID: 22073822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
